Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences between Ecstasy-using and nonusing methamphetamine users.

Mary-Lynn Brecht1, Christina von Mayrhauser

  • 1Integrated Substance Abuse Programs, Neuropsychiatric Institute, University of California, Los Angeles, California 90025, USA.

Journal of Psychoactive Drugs
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Death Literacy in a United States Community: A Cross-Sectional Study.

Omega·2026
Same author

Neonatal Cerebrovascular Stability Index and Oxygenation With 3-Month Neurodevelopmental Outcomes.

JACC. Advances·2026
Same author

Exploring the Quality of TikTok-Based Diabetes Self-Management Education in English and Spanish: A Digital Health Study.

The science of diabetes self-management and care·2026
Same author

Neonatal and 3-month cerebrovascular oxygenation, stability, and extraction in congenital heart disease versus control infants.

Journal of clinical and translational science·2025
Same author

Social Media Integration, Social Support, and Depression Among Older Adults.

Research in gerontological nursing·2025
Same author

Association of preoperative cerebral oxygenation with concurrent neurobehavioral scores in term neonates with congenital heart disease compared to healthy controls.

Frontiers in pediatrics·2025
Same journal

Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study.

Journal of psychoactive drugs·2026
Same journal

Cannabis-Induced Persistent Perceptual Disturbances: A Clinical Characterization Study of Multimodal Sensory Symptoms in 13 Patients.

Journal of psychoactive drugs·2026
Same journal

Specialist Inpatient Detoxification from Gabapentinoids: Clinical and Demographic Characteristics and Predictors of Outcome.

Journal of psychoactive drugs·2026
Same journal

Urine Prevalence of Psychoactive Substances, Nicotine Exposure and Associated Factors Among Commercial Drivers. An Exploratory Study.

Journal of psychoactive drugs·2026
Same journal

Latent Clusters of Peer Behaviors in Childhood and Relevance for Understanding Substance Use in Early Adolescence.

Journal of psychoactive drugs·2026
Same journal

Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.

Journal of psychoactive drugs·2026
See all related articles

Ecstasy and methamphetamine (MA) users exhibit distinct sociodemographic and behavioral patterns compared to MA-only users. Ecstasy use is linked to lower treatment completion rates for stimulant addiction.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Public Health

Background:

  • Rising Ecstasy (MDMA) use raises concerns about potential long-term neurological and cognitive impacts.
  • Ecstasy is frequently used in polydrug contexts, particularly with methamphetamine (MA).

Purpose of the Study:

  • To examine differences between clients treated for MA use who also use Ecstasy versus those who do not.
  • To explore the relationship between Ecstasy use and treatment outcomes in MA-using populations.

Main Methods:

  • Multivariate logistic regression analysis.
  • Comparison of sociodemographic, substance abuse, lifestyle, and treatment characteristics between Ecstasy+MA users and MA-only users.

Main Results:

  • Ecstasy+MA users presented with higher income, fewer children, a broader history of drug use, and used Ecstasy to enhance sexual experiences.

Related Experiment Videos

  • This group reported more drug-related problems, engaged in same-sex partnerships, were younger at admission, and had lower treatment completion rates.
  • Ecstasy use predicted lower treatment completion, though not time to relapse.

    • Conclusions:

    • Findings highlight distinct profiles of stimulant users, aiding research into Ecstasy's behavioral correlates.
    • Results may inform specialized treatment approaches for MA users who also use Ecstasy.